Substrate-dependent regulation of MAO-A in rat mesangial cells: Involvement of dopamine D2-like receptors

American Journal of Physiology - Renal Physiology

Volumn 284, Issue 1 53-1, 2003, Pages

  Pizzinat, Nathalie ^a   Marchal Victorion, Sophie ^a   Maurel, Agnes ^a   Ordener, Catherine ^a   Bompart, Guy ^a   Parini, Angelo ^a  

^a CHU RANGUEIL   (France)

Author keywords

5 hydroxytryptamine; Dopamine receptors; Monoamine oxidase A; Proximal tubule cells

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 BROMO CYCLIC AMP; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BROMOCRIPTINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DACTINOMYCIN; DOMPERIDONE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; QUINPIROLE; SULPIRIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME REGULATION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; KIDNEY PROXIMAL TUBULE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS; WESTERN BLOTTING;

EID: 0037214013     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00113.2002     Document Type: Article

References (40)

1. Aperia AC. Intrarenal dopamine: A key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62: 621-647, 2000.
2. Barili P, Ricci A, Baldoni E, Mignini F, and Amenta F. Pharmacological characterisation and autoradiographic localisation of a putative dopamine D3 receptor in the rat kidney. Eur J Pharmacol 338: 89-95, 1997.
3. Bompart G, Copin N, Djouadi F, Bastin J, Ordener C, and Parini A. Monoamine oxidase in developing rat renal cortex: effect of dexamethasone treatment. Eur J Pharmacol 415: 19-26, 2001.
4. Chakravorty SG and Halbreich U. The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 33: 229-233, 1997.
5. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid gnanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Collins GG, Pryse-Davies J, Sandler M, and Southgate J. Effect of pretreatment with oestradiol, progesterone and DOPA on monoamine oxidase activity in the rat. Nature 226: 642-643, 1970.
7. Cumming P, Ase A, Laliberte C, Kuwabara H, and Gjedde A. In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. J Cereb Blood Flow Metab 17: 1254-1260, 1997.
8. Fernandes MH and Soares-da-Silva P. Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine. J Neural Transm Suppl 41: 101-105, 1994.
9. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, and Couser WG. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40: 477-488, 1991.
10. Hwang O, Park SY, and Kim KS. Protein kinase A coordinately regulates both basal expression and cyclic AMP-mediated induction of three catecholamine-synthesizing enzyme genes. J Neurochem 68: 2241-2247, 1997.
11. Iwata S, Nomoto M, Kaseda S, Tanoue S, Shimosaka M, and Fukuda T. TH protein and mRNA in nigrostriatal dopaminergic neurons are down-regulated by continuous but not intermittent apomorphine. Brain Res Mol Brain Res 82: 133-136, 2000.
12. Jose PA, Eisner GM, and Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 80: 149-182, 1998.
13. Jose PA, Eisner GM, and Felder RA. Renal dopamine and sodium homeostasis. Curr Hypertens Rep 2: 174-183, 2000.
14. Kalaria RN and Harik SI. Differential postnatal development of monoamine oxidases A and B in the blood-brain barrier of the rat. J Neurochem 49: 1589-1594, 1987.
15. Lekas P, Tin KL, Lee C, and Prokipcak RD. The human cytochrome P450 1A1 mRNA is rapidly degraded in HepG2 cells. Arch Biochem Biophys 384: 311-318, 2000.
16. Leung TK, Lim L, and Lai JC. Brain regional distributions of monoamine oxidase activities in postnatal development in normal and chronically manganese-treated rats. Metab Brain Dis 8: 137-149, 1993.
17. Lim J, Yang C, Hong SJ, and Kim KS. Regulation of tyrosine hydroxylase gene transcription by the cAMP-signaling pathway: Involvement of multiple transcription factors. Mol Cell Biochem 212: 51-60, 2000.
18. Lyles GA. Effects of L-DOPA administration upon monoamine oxidase activity in rat tissues. Life Sci 22: 603-609, 1978.
19. Ma ZQ, Bondiolotti GP, Olasmaa M, Violani E, Patrone C, Picotti GB, and Maggi A. Estrogen modulation of catecholamine synthesis and monoamine oxidase A activity in the human neuroblastoma cell line SK-ER3. J Steroid Biochem Mol Biol 47: 207-211, 1993.
20. Missale C, Nash SR, Robinson SW, Jaber M, and Caron MG. Dopamine receptors: From structure to function. Physiol Rev 78: 189-225, 1998.
21. Niquet J and Charli J. In vitro expression of tyrosine hydroxylase by a subpopulation of rat melanotrophs is down-regulated by dopamine. Brain Res Bull 51: 479-484, 2000.
22. Parent MB, Habib MK, and Baker GB. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine. Biochem Pharmacol 59: 1253-1263, 2000.
23. Petkov VD, Petkov VV, and Stancheva SL. Age-related changes in brain neurotransmission. Gerontology 34: 14-21, 1988.
24. Pizzinat N, Girolami JP, Parini A, Pecher C, and Ordener C. Serotonin metabolism in rat mesangial cells: Involvement of a serotonin transporter and monoamine oxidase A. Kidney Int 56: 1391-1399, 1999.
25. Saura J, Richards JG, and Mahy N. Age-related changes on MAO in B1/C57 mouse tissues: A quantitative radioautographic study. J Neural Transm Suppl 41: 89-94, 1994.
26. Schlondorff D. The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1: 272-281, 1987.
27. Sealfon SC and Olanow CW. Dopamine receptors: From structure to behavior. Trends Neurosci 23: S34-S40, 2000.
28. Shih JC, Chen K, and Ridd MJ. Monoamine oxidase: From genes to behavior. Annu Rev Neurosci 22: 197-217, 1999.
29. Shultz PJ, Sedor JR, and Abboud HE. Dopaminergic stimulation of cAMP accumulation in cultured rat mesangial cells. Am J Physiol Heart Circ Physiol 253: H358-H364, 1987.
30. Soares-da-Silva P, Vieira-Coelho MA, and Pestana M. Antagonistic actions of renal dopamine and 5-hydroxytryptamine: Endogenous 5-hydroxytryptamine, 5-HT1A receptors and antinatriuresis during high-sodium intake. Br J Pharmacol 117: 1193-1198, 1996.
31. Stancheva S, Grahovska T, and Petkov VV. Ontogenetic development of the monoamine oxidase activity and of the metabolism of biogenic monoamines in rat brain. Acta Physiol Pharmacol Bulg 11: 3-9, 1985.
32. Vallone D, Picetti R, and Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev 24: 125-132, 2000.
33. +-ATPase during high-salt diet in young but not in adult rats. Am J Physiol Gastrointest Liver Physiol 275: G1317-G1323, 1998.
34. Vindis C, Seguelas MH, Bianchi P, Parini A, and Cambon C. Monoamine oxidase B induces ERK-dependent cell mitogenesis by hydrogen peroxide generation. Biochem Biophys Res Commun 271: 181-185, 2000.
35. 2 produced by monoamine oxidase. Kidney Int 59: 76-86, 2001.
36. Volz HP, Gleiter CH, Waldmeier PC, Struck M, and Moller HJ. Brofaromine - A review of its pharmacological properties and therapeutic use. J Neural Transm 103: 217-245, 1996.
37. Weyler W, Hsu YP, and Breakefield XO. Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47: 391-417, 1990.
38. Youdim MB, Banerjee DK, Kelner K, Offutt L, and Pollard HB. Steroid regulation of monoamine oxidase activity in the adrenal medulla. FASEB J 3: 1753-1759, 1989.
39. Zhu QS, Chen K, and Shih JC. Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. J Neurosci 14: 7393-7403, 1994.
40. Zhu QS, Grimsby J, Chen K, and Shih JC. Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. J Neurosci 12: 4437-4446, 1992.